Search

Your search keyword '"Pries-Heje, Mia"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Pries-Heje, Mia" Remove constraint Author: "Pries-Heje, Mia"
148 results on '"Pries-Heje, Mia"'

Search Results

3. Association Between Vegetation Size and Outcome in the Partial Oral Antibiotic Endocarditis Treatment Trial

4. Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk

6. Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study

7. Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial

8. The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines

9. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers

10. Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors

11. The impact of partial-oral endocarditis treatment on anxiety and depression in the POET trial

12. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

14. Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies

15. 2409. Potential candidates for partial oral treatment in patients with endocarditis at a US center

16. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis

17. Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.

18. Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis

19. Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies

20. Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination

22. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study.

24. Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy

25. Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study

26. Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection

27. Attainment of target antibiotic levels by oral treatment of left-sided infective endocarditis:a POET substudy

28. Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study

30. Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

31. Effect of influenza vaccination on risk of COVID-19 – A prospective cohort study of 46,000 health care workers

32. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls

33. Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

35. Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46 000 Healthcare Workers

36. Antibody Responses and Risk Factors Associated With Impaired Immunological Outcomes Following Two Doses of BNT162b2 COVID-19 Vaccination in Patients With Chronic Pulmonary Diseases

37. Genomic identification of streptococcal strains and relation to clinical characteristics. A substudy to The Partial Oral Treatment of Endocarditis (POET) Trial.

38. Humoral response to two doses of BNT162b2 vaccination in people with HIV

39. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

40. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis

41. Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming

42. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis.

43. Humoral response to two doses of BNT162b2 vaccination in people with HIV.

44. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers

45. Coronary risk of patients with valvular heart disease: prospective validation of CT-Valve Score

46. Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized controlled trial

47. Meeting abstracts from the 7th Danish Emergency Medicine Conference

48. Coronary risk stratification of patients with newly diagnosed heart failure

49. The Copenhagen Triage Algorithm is non-inferior to a traditional triage algorithm: A cluster-randomized study

Catalog

Books, media, physical & digital resources